Article
[Difficult-to-treat patients with chronic hepatitis C].
Praxis - 20 Sept 2006
Zeuzem S
Abstract excerpt
Combination therapy with pegylated interferon-alpha plus ribavirin is the current standard of care. Undetectable HCV-RNA in serum by a sensitive molecular test six months after the end of treatment is the primary aim of antiviral therapy in patients with hepatitis C. The group of "difficult-to-treat" patients is heterogeneous and comprises patients with a difficult indication for antiviral therapy (asymptomatic,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
